This clinical significance is underscored by the correlation between reduced Sestrin3 expression and diminished patient survival, while Sestrin3 knockout mice develop increased tumor burden with elevated CD133/CD44 expression in diethylnitrosamine/choline-deficient high-fat diet (DEN/CD-HFD) models (404). The gene discussed is PROM1; the disease is neoplasm.